COMMUNIQUÉS West-GlobeNewswire

Communiqué de presse: Le lunsekimig de Sanofi a atteint les critères d’évaluation principal et secondaires clés dans les études respiratoires de phase 2 dans l’asthme et la rhinosinusite chronique avec polypose nasale
07/04/2026
Le lunsekimig de Sanofi a atteint les critères d’évaluation principal et secondaires clés dans les études respiratoires de phase 2 dans l’asthme et la rhinosinusite chronique avec polypose nasale L’étude de phase 2b [...]
Pharming Group to participate in April investor conferences
07/04/2026
Leiden, the Netherlands, April 7, 2026: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced that its management will participate in the following investor conferences in the month [...]
SPINEWAY : Minutes of the General Meeting of April 2, 2026
07/04/2026
Ecully, April 7, 2026 – 8:00 a.m. SPINEWAY Minutes of the General Meeting of April 2, 2026 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice on Thursday 2 April [...]
SPINEWAY : Compte-rendu de l’Assemblée Générale du 2 avril 2026
07/04/2026
Ecully, le 7 avril 2026 – 8h00 SPINEWAY Compte-rendu de l’Assemblée Générale du 2 avril 2026 L'Assemblée Générale Mixte (Ordinaire et Extraordinaire) des actionnaires de Spineway s'est tenue sur première convocation ce [...]
Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
07/04/2026
Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP The AIRCULES phase 2b study achieved its primary and key secondary endpoints in moderate-to-severe asthma [...]
MemoGenesis Claims Evaluated: Researching the Latest Memo Genesis Formulation Facts
07/04/2026
A 2026 informational consumer overview of MemoGenesis cognitive health formulation details, honey trick ingredient research context, pricing structure, refund terms, and what consumers should verify before purchasing [...]
Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter
07/04/2026
Strong growth in February/March following January seasonality Net revenue approaches US$100M since launch NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in [...]
Renovare Therapeutics, Inc. Announces Company Launch and Collaboration with CU Boulder Awardee of up to $33.5 Million in ARPA-H Funding to Advance Osteoarthritis Regenerative Therapies
06/04/2026
BOULDER, Colo., April 06, 2026 (GLOBE NEWSWIRE) -- Renovare Therapeutics, Inc., a privately-held biotechnology company pioneering regenerative therapeutics for osteoarthritis, today announced its formal launch from [...]
Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM
07/04/2026
Statistically significant (p<0.0477) DFU wound closure at 12 weeks RCT compared PuraPly®AM plus standard of care to standard of care alone Results strengthen existing clinical evidence supporting future coverage [...]
Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement
07/04/2026
MELBOURNE, Australia and INDIANAPOLIS, April 07, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) provides a market update on its commercial and operational performance for the [...]
Nanox to Report Fourth Quarter 2025 Financial Results on April 20, 2026
06/04/2026
PETACH TIKVA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial [...]
Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy
06/04/2026
EPO Greenlights Claims Covering Preventative use of therapy targeting 5-HT4 Pathway and Expands Silo Pharma IP Portfolio SARASOTA, FL, April 06, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “ [...]
Neuronetics Announces Chief Financial Officer Transition
06/04/2026
Reaffirms Fiscal Year 2026 Financial Guidance MALVERN, Pa., April 06, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and [...]
Cytokinetics to Participate in the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
SOUTH SAN FRANCISCO, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to participate in a fireside chat at [...]
Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
06/04/2026
- YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses - YUVIWEL is now commercially available in the U [...]
Outset Medical Names Derick Elliott as Executive Vice President of Commercial
06/04/2026
SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and [...]
Metabo Drops Claims Evaluated: Recent Investigation Into MetaboDrops Official Website Announcement
06/04/2026
A 2026 informational overview of Metabo Drops coffee metabolism drop marketing claims, proprietary blend label disclosures, ingredient dosage research context, pricing structure, 60-day guarantee terms, and what men and [...]
Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that Ben [...]
GlucoZen Claim Evaluated: Highly-Effective Blood Sugar Support for Natural Glucose Harmony
06/04/2026
A 2026 consumer informational overview of GlucoZen's blood sugar support ingredient research, glucose harmony positioning, pricing and guarantee details, and what adults exploring natural metabolic support options [...]

Pages